Fibroblasts constitute a significant proportion of the stromal compartment in many solid tumors and these infiltrating cells can acquire an activated cancer-associated fibroblast (CAF) phenotype. There is now extensive evidence functionally implicating CAFs in tumor progression via their ability to deposit and remodel extracellular matrix components, secrete pro-tumorigenic factors and modulate the immune compartment.
In breast cancer this so-called ‘desmoplastic response’ shows a clinical correlation with invasion and poor patient prognosis. In addition, there is an increasing body of data supporting a role of CAFs in promoting resistance to chemotherapy and targeted agents.
Despite the growing interest in the functional role of CAFs in tumors, much of their biology remains a mystery because of the lack of specific markers, as well as fibroblast phenotypic plasticity and heterogeneity both in vivo and in vitro.
Together, these have hampered efforts to disentangle the mechanisms underlying tumor:fibroblast crosstalk that could reveal novel strategies for disrupting stromal activation and thereby enhancing therapeutic targeting of tumor cells.
Using in vivo models researchers identify Wnt7a as a key factor secreted exclusively by aggressive breast tumor cells, which induces CAF conversion.
Functionally, this results in extracellular matrix remodelling to create a permissive environment for tumor cell invasion and promotion of distant metastasis.
Mechanistically, Wnt7a-mediated fibroblast activation is not dependent on classical Wnt signalling. Instead, authors demonstrate that Wnt7a potentiates TGFβ receptor signalling both in 3D in vitro and in vivo models, thus highlighting the interaction between two of the key signalling pathways in development and disease.
Importantly, in clinical breast cancer cohorts, tumor cell Wnt7a expression correlates with a desmoplastic, poor-prognosis stroma and poor patient outcome.
http://www.nature.com/ncomms/2016/160118/ncomms10305/full/ncomms10305.html
Tumor:fibroblast crosstalk mechanism to promote cancer aggressiveness
- 1,799 views
- Added
Edited
Latest News
Role of ECM in brain memory
By newseditor
Posted 13 May
All individuals with two co…
By newseditor
Posted 12 May
Autoantibody patterns in pa…
By newseditor
Posted 12 May
How brains convert sounds t…
By newseditor
Posted 12 May
Mice with traits of Tourett…
By newseditor
Posted 11 May
Other Top Stories
Autoimmune disease associated with testicular cancer discovered!
Read more
New mechanism of action of breast cancer gene BRCA1
Read more
Tumor milieu important for cancer growth!
Read more
CIRI model system to predict cancer patient outcomes!
Read more
How Inflammation Causes Gastric Cancer
Read more
Protocols
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
Publications
Antigen-specific Fab profil…
By newseditor
Posted 12 May
Differential representation…
By newseditor
Posted 12 May
Glucose hypometabolism prom…
By newseditor
Posted 12 May
Organellophagy regulates ce…
By newseditor
Posted 12 May
Decoding mitochondria's rol…
By newseditor
Posted 11 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar